|
Soy protein is a safe and nutritious substance
when consumed in amounts two to three times the effective daily
intake proposed to achieve a cholesterol-lowering response (Goldberg
et al, 1982)(2). However, increased consumption of any substance
could potentially be associated with adverse effects in some individuals
which might not be observed at low or moderate intakes. The potential
adverse effects associated with ingestion of large amounts of soy
protein which have been identified include allergenicity, fluctuations
in reproductive hormones, decreased protein, decreased mineral bioavailability,
and exposure to trypsin inhibitors. However, the data do not support
that any one of these would pose a substantial threat to the health
of the U.S. population.
Allergenicity. As
a foreign protein entering the body through the gastrointestinal
tract, soy protein has a potential for eliciting an allergic reaction.
The 2-S globulin fraction of glycinin and beta conglycinin are believed
to be the allergens responsible for hypersensitivity reactions which
develop in some individuals exposed to soy protein (Leiner, 1981).
Use of heat or hot aqueous alcohol in the processing of soybeans
destroys the immunochemical reactivity of most protein components.
Despite these precautions, a small percentage of infants dependent
on soy formulas may experience adverse reactions to soy protein
as an allergen largely because they have an immature immune system
(Van Sickel et al, 1985).
Soy foods, in addition to cows milk,
wheat, peanut, egg, and fish are not recommended for children younger
than two years who have been identified to be at high risk for developing
food allergies. High risk children include those who have exhibited
atopic diseases such as asthma, rhinitis, and eczema or who have
a parent who has a history of these diseases (Sampson and McCaskill,
1985). Most children eventually outgrow their food allergies over
time (Sampson and Scanlon, 1989). Soy and seafood allergies are
among those likely to be outgrown in contrast to allergies to milk,
egg white, or peanuts.
Food allergies typically develop during infancy
or in young children. Onset in children at ages older than four
or in adults is an unusual occurrence because sensitization to allergens
is considered a manifestation of an immature digestive tract, unless
the individual has a family history and no previous exposure to
the allergen (Buscinco et al, 1993). It is not known whether the
incidence of soy protein allergies will increase if the numbers
of individuals currently consuming this protein source increase.
However, such a possibility seems remote since even among infants,
the population group at highest risk of developing allergies of
any kind, the prevalence of soy protein allergies is very small.
Hormonal Disturbances.
As has been demonstrated by the research presented in this petition,
soy isoflavones found in the protein fraction contribute to the
cholesterol-lowering effects observed with ingestion of soy protein.
Concern that these weakly estrogenic-antiestrogenic isoflavones
may influence hormone levels in humans was initially raised more
than 50 years ago by a report of infertility in sheep grazing on
subterranean clover in western Australia (Moule et al, 1970). This
particular clover (Trifolium subterranean L.) is a source of isoflavones.
However, research on the reproductive effects of soy isoflavones
which assessed reproductive hormone concentrations and organ weights
at necropsy in primates did not reveal any adverse findings related
to reproductive ability in either males or females (Anthony et al,
1996b, Honore et al, 1997). Other data from primates have also indicated
that the estrogenic effects of soy isoflavones may be selective,
affecting breast tissue, but not reproductive tissue, in surgically
postmenopausal macaques (Cline et al, 1996). Further, most domesticated
animals and fowl are fed soy-based chow rations and fertility is
not a reported problem.
Limited data in humans suggest that ingestion
of soy isoflavones may actually be beneficial for adult women. Soy
phytoestrogens are believed to be the protective factor responsible
for the low rates of breast cancer among women in populations where
large amounts of soy protein are regularly consumed (Lee et al,
1991). In one controlled study (Cassidy et al, 1994), the effect
of ingesting 45 mg of isoflavones daily from 60 g of soy protein
for a period of one month was examined in six nonvegetarian premenopausal
women between the ages of 21 and 29. The changes in menstrual cycle
length and hormone levels observed in these women were similar to
those reported in response to treatment with tamoxifen, which is
currently being tested as a prophylactic agent for breast cancer.
Protein Quality.
Substitution of soy protein for a proportion of the animal protein
content of the U.S. diet will change the amino acid composition
of the diet. Because lower biological values have been attributed
to plant protein, this change may be a cause of concern for some
individuals. The validity of these concerns can be challenged on
face value by the more optimal health status found among vegetarians
compared with the general U.S. population (White and Frank, 1994).
Furthermore, the biological value of soy protein is superior to
other plant proteins and is equivalent to animal protein sources
(FAQ/WHO, 1991). The quantities and proportions of essential amino
acids provided by soy protein are sufficient to meet human needs
from age 2 to adulthood.
The previously-held belief that soy protein
had a lower biological value than animal protein was based on analytical
data demonstrating that methionine was a limiting amino acid in
soy protein. However, these data were derived from older methods
of assessing protein quality that are not the standards used today.
Prior to 1993, protein quality was evaluated by calculating a protein
efficiency ratio (PER) which measured the growth response of weanling
rats fed different levels of a protein. This index substantially
underestimates the quality of soy protein because the requirement
for sulfur-containing amino acids is much higher for rats than for
humans. Rapidly growing rats need greater amounts of methionine
than do humans to support growth of body hair (Steinke and Hopkins,
1983). Consequently, it is estimated that the amount of methionine
needed to meet human growth requirements are as much as 50% lower
than the requirement for animals.
Since 1993, protein quality has been evaluated
by use of the protein digestibility-corrected amino acid score (PDCAAS),
which was adopted by FDA to replace the PER for food labeling purposes.
The PDCAAS is recognized by the Food and Agriculture Organization
and the World Health Organization as a more accurate standard for
assessing protein quality than the previously used PER. The PDCAAS
takes into account protein digestibility, amino acid profile, and
the ability of the amino acid profile to meet the needs of 2-5 year
old children, the population subgroup having the highest protein
needs other than infants. Using the PDCAAS, the protein quality
of isolated soy protein is identical to that of casein and egg white,
and higher than that of proteins found in beef, kidney beans, pinto
beans, lentils, peanuts, and wheat (FAOIWHO, 1991).
Decreased Mineral Bioavailability.
Soybeans are rich sources of phytic acid and dietary fiber both
of which have well-documented effects on reducing bioavailability
of divalent minerals. The extraction of soy protein from soybean
flakes to produce ISP and other sources of soy protein retains some
part of the phytate and fiber components with the protein fraction
in amounts thatvary with the processing method used. Lectins, another
component of soybeans, were believed to interfere with nutrient
absorption by binding to the intestinal wall (Leiner 1979). However,
lectins have not been found to adversely affect growth, which indicates
that any effects they may have on nutrient availability, are not
biologically significant (Leiner, 1981).
In general, bioavailability of minerals from
plant sources is typically lower than from animal sources. Absorption
of divalent minerals such as calcium, magnesium, zinc, copper, and
iron appears to be less efficient when consumed from leguminous
plants such as soybeans, but ingestion of minerals from other dietary
sources concurrently with soy protein does not reduce the bioavailability
of minerals provided by these sources (Leiner, 1981). This observation
is an important one because it supports the practice of mineral
fortification of products containing soy protein to compensate for
reduced availability of minerals naturally provided in these soy
foods (Erdman, 1981).
Most of the data regarding the effects of
soy protein on mineral balance have been obtained from studies using
animal models. Studies in human subjects have yielded less conclusive
results and suggest that the effects of soy protein ingestion on
mineral balance in humans can not be predicted from animal studies
(Erdman, 1981). The research to date suggest that zinc and iron
nutriture may be most significantly affected by ingestion of soy
products (Erdman and Fordyce, 1989). The primary component responsible
for this reduced bioavailability is phytate which has strong mineral-chelating
properties (Erdman, 1981; Erdman and Fordyce, 1989). Phytate is
distributed throughout the intact soybean, but when the soybean
cotyledon cell is disrupted during processing, it complexes with
the primary soy protein, glycinin.
Depending upon pH, ionic strength and other
conditions associated with processing, phytate can also form complexes
with other components of the soybean including minerals. These conditions,
which include extraction pH, temperature, and fermentation with
yeast enzymes, may either positively or negatively alter the binding
affinity of phytate for minerals. Any reduction in mineral bioavailability
may be overcome by the usual measures generally recommended for
improving availability from processed plant sources. Fortification
is one approach since phytate would not reduce the availability
of minerals from other sources. Another approach might be recommending
ingestion of 100 mg of ascorbic acid or small amounts of animal
protein concurrently with soy products since each improved absorption
of heme and nonheme iron in human subjects consuming soy protein
(Morck et al, 1982; Lynch et al, 1985). This approach is currently
recommended for improving iron absorption from other plant sources
such as whole wheat.
Although mineral absorption may be less efficient
from soy protein sources compared with animal protein sources, overall
mineral balance has not been found to be adversely compromised.
Ingestion of soy protein may result in metabolic effects which could
actually improve retention of some minerals such as calcium. With
lower daily losses, requirements for these minerals are lower. The
positive effects of soy protein ingestion on reducing mineral losses
should be taken into account when the impact of soy protein on mineral
status is evaluated. For example, soy protein is less hypercalciuric
than animal protein and does not inhibit vitamin D activation as
does phosphate-rich animal protein (Breslau et al, 1988; Portale
et al, 1986). Consequently, despite a lower bioavailability of calcium
from soy protein, less calcium is lost in the urine and thus mineral
balance may not be adversely impacted. In addition, several studies
have also indicated that bone resorption may be inhibited by ingestion
of soy isoflavones from soy protein sources such as ISP (Potter
et al, 1998; Brandi, 1992).
Exposure to Trypsin Inhibitors.
Soybeans are a dietary source of trypsin inhibitors. These compounds
are protease inhibitors which have been the subject of some debate
in the past. The controversial nature of trypsin inhibitors and
other protease inhibitors has stemmed primarily from reports suggesting
that these compounds may be potent stimulators of pancreatic hyperplasia
and hypertrophy in animals, and thus could act as cancer promoters
in the presence of chemicals which are carcinogenic to pancreatic
cells (Roebuck, 1986). Different sources of soy protein may vary
widely in the amounts of trypsin inhibitors they contain, but heat
treatment removes most of the activity of these compounds through
denaturation (Anderson and Wolf, 1995).
Recent reports have suggested that any previous
concern about the association between trypsin inhibitors and risk
of pancreatic cancer may have been overstated. Protease inhibitors
have been reported to suppress carcinogenesis (Kennedy, 1995), and
dietary patterns which include foods containing soy protein have
been associated with low rates of a number of cancers (Adlercreutz
and Mazur, 1997). Generalizeabiity of data obtained from studies
in animals to the human condition may be particularly inappropriate
because the animal studies used full fat soy flour and thus the
results were likely confounded by the high amounts of fat also consumed
from the diets fed to these animals (Erdman, 1981). In addition,
there may be species differences in pancreatic of the sensitivity
to the proliferative effects of trypsin inhibitors. The size pancreas
relative to body weight appears to be a factor determining its proliferative
response to trypsin inhibitors. Even among animal models, species
with pancreas sizes <0.3% of body weight tend to be less sensitive
to the proliferative effects of trypsin inhibitors than those with
pancreases comprising a larger percentage of body weight (Leiner,
1979). Since the human pancreas is <0.1% of body weight, it is
likely that it would not be sensitive to the effects of the small
amounts of trypsin inhibitors found in soy protein (Erdman, 1981).
Furthermore, most human pancreatic cancer is ductal in origin (Kennedy,
1995), yet trypsin inhibitors specifically stimulate acinar cellular
proliferation (Roebuck, 1986).
|